PCK2 and cancer: The key enzyme mediating gluconeogenesis, phosphoenolpyruvate carboxykinase (PEPCK), has been recently discovered to replenish glycolytic pools in cancer cells of different origins and thus to mediate abbreviated gluconeogenesis [9, 10, 11, 12, 13].